415 related articles for article (PubMed ID: 19924668)
1. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
Chawla B; Agarwal P; Tandon R; Titiyal JS; Sharma N; Agarwal T; Navak N; Satpathy G
Eur J Ophthalmol; 2010; 20(2):300-5. PubMed ID: 19924668
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibiotic susceptibility to fluoroquinolones].
Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
Kowalski RP; Kowalski TA; Shanks RM; Romanowski EG; Karenchak LM; Mah FS
Cornea; 2013 Jun; 32(6):830-4. PubMed ID: 23132444
[TBL] [Abstract][Full Text] [Related]
4. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
Duggirala A; Joseph J; Sharma S; Nutheti R; Garg P; Das T
Indian J Ophthalmol; 2007; 55(1):15-9. PubMed ID: 17189881
[TBL] [Abstract][Full Text] [Related]
5. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Alexandrakis G; Alfonso EC; Miller D
Ophthalmology; 2000 Aug; 107(8):1497-502. PubMed ID: 10919897
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Keratitis in Toronto: A 16-Year Review of the Microorganisms Isolated and the Resistance Patterns Observed.
Tam ALC; Côté E; Saldanha M; Lichtinger A; Slomovic AR
Cornea; 2017 Dec; 36(12):1528-1534. PubMed ID: 28938380
[TBL] [Abstract][Full Text] [Related]
7. [Antibiotic susceptibility patterns of bacteria isolated from keratitis and intraocular infections at Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia].
Galvis V; Tello A; Guerra A; Acuña MF; Villarreal D
Biomedica; 2014 Apr; 34 Suppl 1():23-33. PubMed ID: 24968033
[TBL] [Abstract][Full Text] [Related]
8. Microbial keratitis in Waikato, New Zealand.
Pandita A; Murphy C
Clin Exp Ophthalmol; 2011 Jul; 39(5):393-7. PubMed ID: 21176039
[TBL] [Abstract][Full Text] [Related]
9. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
Callegan MC; Ramirez R; Kane ST; Cochran DC; Jensen H
Adv Ther; 2003; 20(5):246-52. PubMed ID: 14964344
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
[TBL] [Abstract][Full Text] [Related]
12. Shifting Trends in Bacterial Keratitis in Taiwan: A 10-Year Review in a Tertiary-Care Hospital.
Hsiao CH; Sun CC; Yeh LK; Ma DH; Chen PY; Lin HC; Tan HY; Chen HC; Chen SY; Huang YC
Cornea; 2016 Mar; 35(3):313-7. PubMed ID: 26764878
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolones in the treatment of bacterial keratitis.
Bower KS; Kowalski RP; Gordon YJ
Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
Reddy AK; Garg P; Alam MR; Gopinathan U; Sharma S; Krishnaiah S
Eye (Lond); 2010 Jan; 24(1):170-4. PubMed ID: 19229279
[TBL] [Abstract][Full Text] [Related]
15. Trends in the Microbiological Spectrum of Nonviral Keratitis at a Single Tertiary Care Ophthalmic Hospital in India: A Review of 30 years.
Joseph J; Karoliya R; Sheba E; Sharma S; Bagga B; Garg P
Cornea; 2023 Jul; 42(7):837-846. PubMed ID: 35942533
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibiotic resistance in bacterial keratitis in London.
Tuft SJ; Matheson M
Br J Ophthalmol; 2000 Jul; 84(7):687-91. PubMed ID: 10873974
[TBL] [Abstract][Full Text] [Related]
17. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
[TBL] [Abstract][Full Text] [Related]
18. Ocular Pathogens and Antibiotic Sensitivity in Bacterial Keratitis Isolates at King Khaled Eye Specialist Hospital, 2011 to 2014.
Al-Dhaheri HS; Al-Tamimi MD; Khandekar RB; Khan M; Stone DU
Cornea; 2016 Jun; 35(6):789-94. PubMed ID: 27078003
[TBL] [Abstract][Full Text] [Related]
19. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
Scoper SV
Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
Chang VS; Dhaliwal DK; Raju L; Kowalski RP
Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]